2017年9月28日星期四

EliKine™ Human IL-6 ELISA Kit joins the Abbkine Scientific family

EliKine™ Human IL-6 ELISA Kit joins the Abbkine Scientific familyIL-6 gene encodes a cytokine, which functions in inflammation as well as the maturation of B cells. This is in addition to the encoded protein being shown to be an endogenous pyrogen capable of inducing fever in people with autoimmune diseases or infections. The - IL 6 Elisa kit is designed having the researcher or investigator in mind.


With human reactivity and colorimetric method of detection and limit of detection of 2 pg/mL, the kit employs a two-site sandwich ELISA to quantitate IL-6 in samples. The BSF2 Elisa kit as it is also referred to as has a calibration range of 3.125 pg/ml-200 pg/ml.


The IL6 Elisa kit has multiple steps standard sandwich ELISA assay with a working time of 3-5 hours, depending on the experience of the operation person. The sample type includes Cell culture supernatants, other biological fluids, Plasma, Serum.


The features and benefits of the kit include its high sensitivity and excellent specificity for detection of Human IL-6. The kit also has no significant cross-reactivity or interference between Human IL-6 and analogues.


Components of the kits include:


  • Human IL-6 microplate

  • Human IL-6 standard

  • Human IL-6 detect antibody

  • EliKine™ Streptavidin-HRP

  • Standard diluent

  • Assay buffer

  • HRP substrate

  • Stop solution

  • Wash buffer

  • Plate covers

Other information about the kit and other research products from Abbkine can be found on the company’s website.


About Abbkine Scientific Co. Ltd


Abbkine Scientific Co. Ltd was founded in 2012. The company set up by a number of scientists and marketing experts in the field of life science in California, USA. The company is headquartered in China and has combined innovative technology from United States with China's manufacturing engineering and cost advantages, providing high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research and drug discovery.

没有评论:

发表评论